Cover Image

De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hanna L. Kleiboeker, Margaret R. Jorgenson, Michael J. Scolarici, Jillian L. Descourouez, Glen E. Leverson, Chris Saddler, Didier Mandlebrot, David Al‐Adra
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Transplantation
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
by: Hanna L. Kleiboeker, et al.
Published: (2025)

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024)

Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
by: John‐Anthony Coppola, et al.
Published: (2025)

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)

Development of cytomegalovirus resistant to maribavir: real world, real problem?
by: Hanna L. Kleiboeker, et al.
Published: (2024)

Cytomegalovirus‐Induced Arterial Intimal Fibrosis in the Kidney Transplant
by: Anukul Ghimire, et al.
Published: (2025)

A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
by: Afolarin A. Otunla, et al.
Published: (2026)

Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Patients in Early Period After Kidney Transplantation
by: Kunhong Deng, et al.
Published: (2025)

Sirolimus Versus Mycophenolate Mofetil in Simultaneous Pancreas–Kidney Transplantation: Impact on Urinary Tract Infection Rates
by: Barbora Píšová, et al.
Published: (2026)

Cytomegalovirus (CMV) Serostatus Reassessment in CMV Seronegative Kidney Transplant Candidates
by: Ajmeet K. Pama‐Ghuman, et al.
Published: (2025)

Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T‐Cell Leukemia/Lymphoma in the Pre‐Letermovir Era
by: Takuya Fukushima, et al.
Published: (2025)

Older Kidney Transplant Patients Are Over Immunosuppressed Using Standard Protocols With Differential Sex‐Based Complications
by: Inji Alshaer, et al.
Published: (2025)

Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
by: Estela Giménez, et al.
Published: (2025)

Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk African American Kidney Transplant Patients
by: Shipra R. Bethi, et al.
Published: (2024)

De Novo Onset of Myasthenia Gravis after Kidney Transplantation
by: Aaron de Souza, et al.
Published: (2024)

Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
by: Hiroki Hosoi, et al.
Published: (2025)

Cytomegalovirus, the Troll of Transplantation and Cellular Therapy?
by: Joseph Sassine, et al.
Published: (2025)

Research Advice for Early Career Transplant Infectious Disease Clinicians
by: Rebecca N. Kumar, et al.
Published: (2025)

Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol
by: Madhumita Rao, et al.
Published: (2025)

Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
by: Christina Oikonomopoulou, et al.
Published: (2025)

Genetic and Functional Evaluation of the Complement System in De Novo Thrombotic Microangiopathy After Transplantation: A Single‐Center Experience
by: Adam Bregman, et al.
Published: (2025)

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)

Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C‐Viremic Donor Kidneys Into Uninfected Recipients: A Multi‐Center Retrospective Cohort Study
by: Vishnu S. Potluri, et al.
Published: (2025)

Impact of Pharmacogenomic Testing in Pediatric Heart and Kidney Transplant
by: Rachel L. Jackson, et al.
Published: (2025)

Reduced Functional Status among Kidney Transplant Recipients over Time and Associated Risks Post‐Transplant
by: Sage L. Dixon, et al.
Published: (2025)

Serum β2‐Microglobulin Predicts Time to Recovery of Delayed Graft Function in Kidney Transplant Recipients
by: Sandesh Parajuli, et al.
Published: (2024)

Medical Distrust Among Kidney Transplant Candidates
by: Valerie L. Thompson, et al.
Published: (2024)

Antibiotic Tolerability in Nocardia Infection Among Kidney Transplant Recipients: A Multicenter Cohort Study
by: M. Pérez‐Mir, et al.
Published: (2026)

Access to Kidney Transplantation for Minority Children With End‐Stage Renal Disease and Predictors of Post‐Transplant Outcome: Impact of Race and Ethnicity
by: Robyn Matloff, et al.
Published: (2025)

Over Three Decades of Growth Hormone Treatment in Children With Chronic Kidney Disease‐Associated Growth Failure Before and After Kidney Transplantation
by: Ora Yadin
Published: (2024)

Comparison of Kidney Allograft Outcomes in Simultaneous Liver‐Kidney Versus Kidney After Liver Transplantation Since the Safety Net Era
by: Brian T. Lee, et al.
Published: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
by: Lemuel R. Non, et al.
Published: (2024)

Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once‐Daily Tacrolimus Formulations: The BITACORA Study
by: Amado Andrés, et al.
Published: (2026)

Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes
by: Neetika Garg, et al.
Published: (2024)

Simultaneous Ureteral Ligation at the Time of Pediatric Kidney Transplantation: A Technical Report
by: Randi J. Ryan, et al.
Published: (2026)

Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?
by: Alexandra R. Monetti, et al.
Published: (2024)

De‐Escalating Medical Evaluation for Kidney Transplantation: A Potential Avenue to Improve Access to Kidney Transplantation
by: Xingxing S. Cheng, et al.
Published: (2026)

Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality
by: Nan‐Su Huang, et al.
Published: (2025)

Successful Management of Refractory Cytomegalovirus Infection After Intestinal Transplantation Using Maribavir
by: Hsi‐Ming Liu, et al.
Published: (2024)